Norbert G. Riedel

Insider Reports History

Entity
Individual
Location
Baxter International Inc, One Baxter Pkwy Df2 1 W, Deerfield, IL
Signature
/s/ James R. Gruber
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Norbert G. Riedel:

Insider Reports Filed by Norbert G. Riedel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETON Eton Pharmaceuticals, Inc. Jan 3, 2025 6 $374K 4 Jan 6, 2025 Director
ETON Eton Pharmaceuticals, Inc. Jan 3, 2025 1 $0 4 Jan 6, 2025 Director
JAZZ Jazz Pharmaceuticals plc Aug 2, 2024 2 -$165K 4 Aug 6, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
ETON Eton Pharmaceuticals, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
JAZZ Jazz Pharmaceuticals plc Aug 11, 2023 2 -$171K 4 Aug 15, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
ETON Eton Pharmaceuticals, Inc. Mar 3, 2023 1 $0 4 Mar 3, 2023 Director
APTX Aptinyx Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 EXECUTIVE CHAIRMAN OF THE BOD, Director
JAZZ Jazz Pharmaceuticals plc Aug 5, 2022 5 -$971K 4 Aug 9, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
ETON Eton Pharmaceuticals, Inc. Feb 7, 2022 1 $0 4 Feb 28, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Jan 4, 2022 2 $0 4 Jan 6, 2022 Director
APTX Aptinyx Inc. Dec 6, 2021 1 $223K 4 Dec 8, 2021 CEO, Director
APTX Aptinyx Inc. Dec 2, 2021 1 $0 4 Dec 7, 2021 CEO, Director
JAZZ Jazz Pharmaceuticals plc Aug 6, 2021 1 -$193K 4 Aug 10, 2021 Director
JAZZ Jazz Pharmaceuticals plc Jul 29, 2021 1 $0 4 Aug 2, 2021 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
APTX Aptinyx Inc. May 17, 2021 3 -$322K 4/A May 20, 2021 CEO, Director